Related Experiment Video
Updated: Apr 10, 2026

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
Levothyroxine Augmentation in Clozapine Resistant Schizophrenia: A Case Report and Review
Ruohollah Seddigh1, Somayeh Azarnik2, Amir-Abbas Keshavarz-Akhlaghi1
1Mental Health Research Center, Iran University of Medical Sciences, Tehran, Iran.
Abstract:
There are many reports that show different thyroid abnormalities in schizophrenia without clear establishment of their role in etiology and treatment outcome of schizophrenia. Among these reports, there are only a few that consider a role for thyroid hormones as augmenting agents in the treatment with antipsychotic drugs. This case report outlines symptom subsidence of a patient with clozapine refractory paranoid schizophrenia and normal thyroid function who added levothyroxine to clozapine and found that symptoms of psychosis returned once levothyroxine was discontinued. Although this observation needs to be confirmed in controlled clinical trials, we aimed to discuss possible hypothesized mechanisms underlying this observation.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Psychosis and Antipsychotic Drugs: Overview
Electroconvulsive Therapy
Antipsychotic Drugs: Typical and Atypical Agents

